When combined with structured lifestyle intervention, GLP-1 receptor agonists represent effective therapeutic options in early T2D management
[1] In moderate deficiencies, feeling tired, feeling faint, mouth ulcers, rapid breathing, upset stomach, pallor, hair loss, decreased ability to think and joint pain and the beginning of neurological symptoms, including abnormal sensations such as, numbness and tingling, and tinnitus may occur
In the digestive system, it slows gastric emptying the rate at which food leaves the stomach prolonging feelings of fullness and reducing the postprandial blood sugar spikes that drive hunger and cravings
Some peptides are also used to support immune health, injury recovery, gut health and healthy aging